Since the cardiac hormones increase lipolysis in obese subjects, as well as helping to alleviate obesity-interrelated hypertension mediated by leptin, this suggests they may be a multi-targeted novel therapy for obesity. The gene discussed is LEP; the disease is hypertensive disorder.